Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Acq. announced
CC transcript
Director departure
Quarterly results
Appointed director
Inv. presentation

STATE STREET CORP (STT) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 SC 13G/A STATE STREET CORP reports a 2.2% stake in EXIT FILING EMERGENT BIOSOLUTIONS INC
10/10/2023 SC 13G/A STATE STREET CORP reports a 2.1% stake in EXIT FILING 2SEVENTY BIO INC
10/10/2023 SC 13G/A STATE STREET CORP reports a 6.3% stake in AMENDED FILING ARCTURUS THERAPEUTICS HOLDINGS INC
10/10/2023 SC 13G/A STATE STREET CORP reports a 2.3% stake in EXIT FILING FATE THERAPEUTICS INC
08/23/2023 4 Aboaf Eric W. (Vice Chairman and CFO) has filed a Form 4 on STATE STREET CORP
Txns: Sold 9,514 shares @ $67.01, valued at $637.5k
Sold 2,372 shares @ $67.63, valued at $160.4k
08/21/2023 144 Form 144 - Report of proposed sale of securities:
08/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/16/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/09/2023 SC 13G/A STATE STREET CORP reports a 6.2% stake in AMENDED FILING AVISTA CORP
08/09/2023 SC 13G/A STATE STREET CORP reports a 5.2% stake in AMENDED FILING SJW GROUP
08/09/2023 SC 13G/A STATE STREET CORP reports a 5.7% stake in AMENDED FILING ONE GAS INC
08/09/2023 SC 13G/A STATE STREET CORP reports a 6.1% stake in AMENDED FILING NU SKIN ENTERPRISES INC
08/09/2023 SC 13G/A STATE STREET CORP reports a 5.3% stake in AMENDED FILING JOHN WILEY & SONS INC
08/09/2023 SC 13G/A STATE STREET CORP reports a 4% stake in EXIT FILING BRADY CORP
08/09/2023 SC 13G/A STATE STREET CORP reports a 5.4% stake in AMENDED FILING LEGGETT & PLATT INC
08/09/2023 SC 13G/A STATE STREET CORP reports a 5.8% stake in AMENDED FILING ABM INDUSTRIES INC
08/03/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Underwriting Agreement, by and among State Street Corporation and Morgan Stanley & Co. LLC, Academy Securities, Inc., Goldman Sachs & Co. LLC and Loop Capital Markets LLC, as representatives of the several underwriters named therein",
"Form of 5.272% Senior Notes due 2026",
"Form of Floating Rate Senior Notes due 2026",
"Opinion of Wilmer Cutler Pickering Hale and Dorr LLP"
08/03/2023 4 Maiuri Louis D (President and COO) has filed a Form 4 on STATE STREET CORP
Txns: Sold 8,800 shares @ $71.96, valued at $633.2k
08/02/2023 424B2 Form 424B2 - Prospectus [Rule 424(b)(2)]:
08/01/2023 144 Form 144 - Report of proposed sale of securities:
07/31/2023 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
07/31/2023 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
07/31/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
07/28/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/14/2023 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "Boston, MA.... July 14, 2023 News Release STATE STREET REPORTS SECOND QUARTER 2023 EPS OF $2.17",
"14, 2023 NYSE: STT 2Q 2023"
07/10/2023 SC 13G STATE STREET CORP reports a 10.5% stake in INITIAL FILING ARDELYX INC
07/10/2023 SC 13G/A STATE STREET CORP reports a 1.6% stake in EXIT FILING ALTIMMUNE INC
07/10/2023 SC 13G/A STATE STREET CORP reports a 1.9% stake in EXIT FILING KARYOPHARM THERAPEUTICS INC
07/10/2023 SC 13G/A STATE STREET CORP reports a 5% stake in EXIT FILING GEVO INC
07/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy